DexCom (Germany) Top Insiders

DC4 Stock  EUR 61.93  0.59  0.96%   
DexCom employs about 11 K people. The company is managed by 15 executives with a total tenure of roughly 25667 years, averaging almost 1711.0 years of service per executive, having 733.33 employees per reported executive. Examination of DexCom's management performance can provide insight into the company performance.
Jacob Leach  CEO
CEO President
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

DexCom Management Team Effectiveness

The company has return on total asset (ROA) of 0.0889 % which means that it generated a profit of $0.0889 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.345 %, meaning that it generated $0.345 on every $100 dollars invested by stockholders. DexCom's management efficiency ratios could be used to measure how well DexCom manages its routine affairs as well as how well it operates its assets and liabilities. At this time, DexCom's Other Current Assets are most likely to increase significantly in the upcoming years.
The DexCom's current Net Income Applicable To Common Shares is estimated to increase to about 412 M, while Common Stock Shares Outstanding is projected to decrease to roughly 245.5 M. DexCom holds a total of 384.86 Million outstanding shares. The majority of DexCom Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in DexCom Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in DexCom. Please pay attention to any change in the institutional holdings of DexCom Inc as this could imply that something significant has changed or is about to change at the company. Also note that almost seven hundred sixty-nine thousand seven hundred thirty invesors are currently shorting DexCom expressing very little confidence in its future performance.
Some institutional investors establish a significant position in stocks such as DexCom in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of DexCom, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

DexCom Workforce Comparison

DexCom Inc is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 24,046. DexCom totals roughly 11,000 in number of employees claiming about 46% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26.

DexCom Inc Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. DexCom Inc Price Series Summation is a cross summation of DexCom price series and its benchmark/peer.

DexCom Notable Stakeholders

A DexCom stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DexCom often face trade-offs trying to please all of them. DexCom's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DexCom's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jacob LeachCEO PresidentProfile
Jereme CPACFO VPProfile
Girish NaganathanExecutive CTOProfile
Matthew DolanExecutive DevelopmentProfile
Donald AbbeyRegulatory, ServicesProfile
Jereme SylvainCFO VPProfile
Paul FlynnEx RevenueProfile
Keri LeoneSenior EducationProfile
Kevin SayerExecutive BoardProfile
Jon ColemanExecutive OfficerProfile
Michael BrownExecutive OfficerProfile
Sadie SternExecutive OfficerProfile
Sean ChristensenDirector RelationsProfile
Steven PacelliEx VenturesProfile
Andrew BaloAccess AffairsProfile
String symbol = request.getParameter("s");

About DexCom Management Performance

The success or failure of an entity such as DexCom Inc often depends on how effective the management is. DexCom management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DexCom management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DexCom management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DEXCOM INC operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2800 people.

DexCom Workforce Analysis

Traditionally, organizations such as DexCom use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DexCom within its industry.

DexCom Manpower Efficiency

Return on DexCom Manpower

Revenue Per Employee423.8K
Revenue Per Executive310.8M
Net Income Per Employee76K
Net Income Per Executive55.8M
Working Capital Per Employee171.9K
Working Capital Per Executive126.1M

Complementary Tools for DexCom Stock analysis

When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon